Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 1, 1999, Pages 57-62

  Islam, Syed ^a,e   Gutin, Bernard ^b   Treiber, Frank ^b   Hobbs, Gerry ^a   Kamboh, Ilyas ^c   Lopes Virella, Maria ^d  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY RISK; DISEASE PREDISPOSITION; FAMILY HISTORY; FITNESS; HUMAN; IMMUNOPHENOTYPING; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL ANALYSIS;

EID: 0032933398     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.1.57     Document Type: Article

References (50)

1. Sandholzer C, Saha N, Kark J, et al. Apo(a) phenotypes predict risk for coronary heart disease: a study of six populations. Arterioscler Thromb Vasc Biol. 1992; 12:1214-1226.
2. Durrington P, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins (a), A1, and 8 and parental history in men with early onset ischemic heart disease. Lancet. 1988;1:1070-1073.
3. Kark J, Sandholzer C, Friedlander Y, Utermann G. Plasma Lp(a), apolipoprotein (a) phenotypes and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis. 1993;98: 139-151.
4. Sandkamp M, Funke H, Schult H, Kohler E, Assmann G. Lipoprotein(a) as independent risk factors for myocardial infarction at a young age. Clin Chem. 1990; 36:20-23.
5. Armstrong V, Cremer P, Eberle E, et al. The association between serum Lp(a) concentration and angiographically assessed coronary arteriosclerosis: dependence on serum LDL level. Atherosclerosis. 1986;62:249-259.
6. Genest J, Jenner J, McNamara J, et al. Prevalence of lipoprotein (a) excess in coronary artery disease. Am J Cardiol. 1991;67:1039-1045.
7. Kostner G, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici G. Lipoprotein Lp(a) and risk of myocardial infarction. Atherosclerosis. 1981;38:51-61.
8. Rhoads G, Dahle G, Berg K, Morton N, Dannenbert A. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986;256:2540-2544.
9. Yla-Herttuala S, Palinski W, Rosenfeld ME. et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Can Invest. 1989;84:1086-1095.
10. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized low-density lipoprotein and progression of carotid atherosclerosis. Lancet. 1992; 339:883-887.
11. Maggi E, Chiesa R, Melissano G. et al. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb. 1994;14:1892-1899.
12. Yla-Herttuala S, Palinski W, Butler S, Picard S, Steinberg D, Witztum J. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
13. Corsetti J, Sterry J, Sparks J, Sparks C, Weintraub M. Effects of weight loss on serum lipoprotein(a) concentrations in an obese population. Clin Chem. 1991; 37:1191-1195.
14. Scanu A, Scandiani L. Lipoprotein(a) structure, biology and clinical relevance. Med J Clin Invest. 1990;85:1790-1805.
15. Huang C, Elin Ruddel M, Schmitz J, Linnola M. The effect of alcohol withdrawal on serum concentration of Lp(a), apoprotein A1, B, and lipids. Alcoholism. 1992; 16:895-898.
16. Kanno H, Saito E, Fujioka T, Yasugi T. Lipoprotein(a) levels in nephrotic syndrome. J Int Med. 1992;31:1004-1008.
17. Howard BV, Le NA, Belcher JD, et al. Concentration of Lp(a) in black and white young adults: relationship to risk factors for cardiovascular disease. Ann Epidemiol. 1994;4:341-350.
18. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chliss G, Hobbs HH. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52-60.
19. Kraft HG, Kochl G, Menzel HJ, Sandholzer C, Uttermann G. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992;90:220-230.
20. Vruwink KG, Gershwin ME, Sachet P, Halpem G, Davis PA. Modification of human LDL by in vitro incubation with cigarette smoke or copper ions: implications for allergies, asthma and atherosclerosis. J Investig Allergol Clin Immunol. 1996,6:294-300.
21. Mahfouz MM, Hulea SA, Kummeron FA. Cigarette smoke increases cholesterol oxidation and lipid peroxidation of human low-density lipoproteins and decreases its binding to the hepatic receptor in vitro. J Environ Pathol Toxicol Oncol. 1995;14:181-192.
22. Scanlon CE, Berger B, Malcolm G, Wissler RW. Evidence for more extensive deposits of epitopes ot oxidized low density lipoproteins in aortas of young people with elevated serum thiocyanate levels: PDAY research group. Atherosclerosis. 1996;121:23-33.
23. Heitzer T, Yla-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction ot forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93:1346-1353.
24. Kabakov AE, Tertov W, Saenko VA, Poverenny AM, Orekhov AN. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation ot cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol. 1502;63:214-220.
25. Lopes-Virella MF, Griffith RL, Shunk KA, Virella GT. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Arterioscler Thmmb. 1991;11:1356-1367.
26. Lopes-Virella MF, Virella GT. Cytokines, modified lipoproteins, and arteriosclerosis in diabetes. Diabetes. 1996;45:540-544.
27. Gisinger C, Virella GT, Lopes-Virella MF. Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macroptiages. Clin Immunol Immunopathol 1991;59:37-52.
28. Griffith RL, Virelia GT, Stevenson HC, Lopes-Virella MF. LDL immune complexes lead to CE accumulation in human macrophages. J Exp Med. 1988;168: 1041-1059.
29. Treiber FA, Davis H, Musante L, et al. Ethnicity, gender, family history of myocardial infarction, and hemodynamic responses to laboratory stressors in children. Health Psychol. 1993;12:6-15.
30. Allain C, Poon L, Chan C, Richmond W. Fu P. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470.
31. 2 precipitation [abstract]. Clin Chem. 1982;28:1574.
32. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:475.
33. Friedewald W, Ley R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem. 1972;18:499-502.
34. Kamboh I, Svitko C, Williams E, Ferrell R, Pollitzer W. Hypervariable polymorphism of apo(a) in blacks and whites as reflected by pnenotyping. Chem Phys Lipids. 1994;67/68:283-292.
35. Kamboh M, Ferrell R, Kottke B. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet. 1991;49:1036-1084.
36. Folch J, Lees H, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497.
37. Mironova M, Virella G, Virella-Lowell I. Lopes-Virella MF. Anti-modified LDL-antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Clin Immunol Immunopathol. 1997;85:73-82.
38. Gutin B, Litaker M, Islam S, Manos T, Smith C, Treiber F. Body composition measurement in 9-11-y-old children by dual-energy X-ray absorptiometry, skinfold-thickness measurements, and bioimpedance analysis. Am J Clin Nutr. 1996;63: 287-292.
39. McArdle W, Katch V. Exercise Physiology. Philadelphia, Pa: Lea & Febiger; 1991: 333.
40. Fisher LD, van Belle G. Biostatistics: A Methodology lor Health Sciences. New York, NY: John Wiley & Sons Inc; 1993:524-531.
41. Strong JP. Landmark perspective: coronary atherosclerosis in soldiers: a clue to the natural history of atherosclerosis in the young. JAMA. 1986;256:2863-2866.
42. Jaakko K, Reijo N, Erikki P, Seppo S. Intimal thickening of the coronary arteries in infants in relation to family history of coronary artery disease. Circulation. 1993; 87:1960-1968.
43. Stary H. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;1:19-32.
44. Islam S, Gutin B, Smith C, Treiber F, Kamboh MI. Association of apolipoprotein (a) phenotypes in children with family history of premature coronary artery disease. Arterioscler Thromb. 1994;14:1609-1616.
45. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low density lipoproteins that increase its atherogenecity. N Engl J Med. 1989;320:915-924.
46. Staprans I, Rapp JH, Xian-Mang P, Kim KY, Feingold KR. Oxidized lipids in the diet are a source of oxidized lipid in chylominous of human serum. Arterioscler Thromb. 1994;14:1900-1905.
47. Belcher J, Balla J, Balla G, et al. Vitamin E, LDL, and endothelium: brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. ArteriosclerThromb. 1993;13:1779-1789.
48. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
49. Berg A, Frey I, Baumstark MW, Halle M, Keul J. Physical activity and lipoprotein lipid disorders. Sports Med. 1994;17:6-21.
50. Houmard JA, Bruno NJ, Bruner RK, McCammon MR, Israel RG, Barakat HA. Effect of exercise training on the chemical composition of plasma LDL. Arterioscler Thromb. 1994;14:325-330.